The Role of Ultrasound Imaging in the Definition of the Stage of Liver Fibrosis in Patients with Chronic Hepatitis C

Dmitry Konstantinov, MD*; Larisa Popova, MD, ScD; Elena Konstantinova, MD, PhD; Anastasia Novikova, PGS

Samara State Medical University; Samara, Russian Federation

*Corresponding author: Dmitry Konstantinov, MD; Samara State Medical University. Samara, Russian Federation. E-mail: dk.samgmu@mail.ru

Published: September 20, 2014.

Abstract: 

The aim of this research was to develop a method for noninvasive staging of liver fibrosis (LF) in patients with chronic hepatitis C (CHC) based on ultrasound imaging (UI) of the abdominal cavity. We examined 124 patients with CHC. The diagnosis was verified on the basis of clinical and epidemiological, serological and molecular biological data. Direct ultrasonic parameters of the structure and hemodynamics of liver and spleen were supplemented with estimated indicators: square of the expected cross-section of ​​the lobes of the liver and spleen, as well as their ratio. On the basis of the discriminant analysis of the survey data of 82 patients, we developed an analytical model (with predictive value of 95.2%) for interval estimation of the fibrosis degree in CHC patients. We have concluded that UI performed on modern equipment, including Doppler, is able to determine the degree of LF without resorting to histological verification.

Keywords: 
chronic hepatitis C; ultrasound; fibrosis.
References: 
  1. Dienstag JL. The role of liver biopsy in chronic hepatitis C. Hepatology 2002; 36 (5 Suppl 1):S152-60.
  2. Saadeh S, Cammell G, Carey WD, Younossi Z, Barnes D, Easley K. The role of liver biopsy in chronic hepatitis C. Hepatology 2001; 33(1):196-200.
  3. Gebo KA, Herlong HF, Torbenson MS, Jenckes MW, Chander G, Ghanem KG, et al. Role of liver biopsy in management of chronic hepatitis C: a systematic review. Hepatology 2002; 36(5 Suppl 1):S161-72.
  4. Seeff LB, Everson GT, Morgan TR, Curto TM, Lee WM, Ghany MG, et al. Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial. Clin Gastroenterol Hepatol 2010; 8(10):877-83.
  5. Smith JO, Sterling RK. Systematic review: non-invasive methods of fibrosis analysis in chronic hepatitis C. Aliment Pharmacol Ther 2009; 30(6):557-76.
  6. Lin ZH, Xin YN, Dong QJ, Wang Q, Jiang XJ, Zhan SH, et al. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis С-related fibrosis: an updated meta-analysis. Hepatology 2011; 53(3):726-36.
  7. Klibansky DA, Mehta SH, Curry M, Nasser I, Challies T, Afdhal NH. Transient elastography for predicting clinical outcomes in patients with chronic liver disease. J Viral Hepat 2012; 19(2):e184-93.

The fully formatted PDF version is available.

Download Article

Int J Biomed. 2014; 4(3):175-178. © 2014 International Medical Research and Development Corporation. All rights reserved.